Robert Petit

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Princeton, NJ
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Robert Petit
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Robert Petit

Form 4 holding Robert Petit is the Chief Medical Officer and Chief Scientific Officer of OS Therapies Incorporated.

OS Therapies Inc

Security class
Common Stock
Shares / value
200,000
Estimated value
$308,000
Report date
22 Jan 2026
Price
$1.54
Ownership
Direct
Form 4 holding Robert Petit is the Chief Medical Officer and Chief Scientific Officer of OS Therapies Incorporated.

OS Therapies Inc

Security class
Stock options (right to buy)
Shares / value
100,000
Estimated value
Report date
22 Jan 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Robert Petit

4 OSTX

OS Therapies Inc

Report period
22 Jan 2026
Transactions
1
Transaction value
$0
Accepted by SEC
13 Feb 2026, 16:41
Role
Robert Petit is the Chief Medical Officer and Chief Scientific Officer of OS Therapies Incorporated.
Next action
Open filing details
4 OSTX

OS Therapies Inc

Report period
21 Oct 2025
Transactions
1
Transaction value
$0
Accepted by SEC
19 Dec 2025, 18:31
Role
Robert Petit is the Chief Medical Officer and Chief Scientific Officer of OS Therapies Incorporated.
Next action
Open filing details
3 OSTX

OS Therapies Inc

Report period
31 Jul 2024
Transactions
0
Transaction value
$0
Accepted by SEC
01 Aug 2024, 09:15
Role
Robert Petit is the Chief Medical Officer and Chief Scientific Officer of OS Therapies Incorporated.
Next action
Open filing details
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .